Alkem Laboratories Limited

5,524.95

INR
-46.25(-0.83%)
As of November 14, 2024 10:00:00 AM

Alkem Laboratories Limited Share Price Information

24 hour Low and High

Low: 5502.7
High: 5657.95

All time High

6366.25

Price Change 1h

+₹-105.05 +-1.87%

Price Change 1d

+₹-105.05 +-1.87%

Price Change 1w

+₹-181.55 +-3.18%

Alkem Laboratories Limited Market Information

Exchange

NSE

Market Cap

69295.09 Cr

About Alkem Laboratories Limited Share

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastro-intestinal, pain/analgesic, anti-diabetic, neuro/central nervous system, gynecology, respiratory, dermatology, and cardiac diseases. It also provides vitamins, minerals, and nutrients, as well as mouth wash, shampoos, pregnancy detection kits, and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

17432

CEO

Mr. S. Venkatesh

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Add Alkem Laboratories, target price Rs 6,180: HDFC Securities
  • Alkem Laboratories Ltd eases for fifth straight session
  • Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models
  • Alkem Labs Q2 Results: Revenue falls but profit and margin expand from last year
  • Q2FY25: Alkem Labs’ profit rises by 11% YoY to Rs 689 crore; revenue falls marginally

FAQs

Alkem Laboratories Limited

5,524.95

INR
-46.25(-0.83%)
As of November 14, 2024 10:00:00 AM

Alkem Laboratories Limited Share Price Information

24 hour Low and High

Low: 5502.7
High: 5657.95

All time High

6366.25

Price Change 1h

+₹-105.05 +-1.87%

Price Change 1d

+₹-105.05 +-1.87%

Price Change 1w

+₹-181.55 +-3.18%

Alkem Laboratories Limited Market Information

Exchange

NSE

Market Cap

69295.09 Cr

About Alkem Laboratories Limited Share

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastro-intestinal, pain/analgesic, anti-diabetic, neuro/central nervous system, gynecology, respiratory, dermatology, and cardiac diseases. It also provides vitamins, minerals, and nutrients, as well as mouth wash, shampoos, pregnancy detection kits, and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

17432

CEO

Mr. S. Venkatesh

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Add Alkem Laboratories, target price Rs 6,180: HDFC Securities
  • Alkem Laboratories Ltd eases for fifth straight session
  • Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models
  • Alkem Labs Q2 Results: Revenue falls but profit and margin expand from last year
  • Q2FY25: Alkem Labs’ profit rises by 11% YoY to Rs 689 crore; revenue falls marginally

FAQs